Mesulergine: a dopamine agonist with novel properties in Parkinson's disease.
Lieberman
A N
AN
New York University School of Medicine, New York.
Gopinathan
G
G
Pasternack
P
P
Goldstein
M
M
D000368:Aged; D015259:Dopamine Agents; D004305:Dose-Response Relationship, Drug; D004359:Drug Therapy, Combination; D004873:Ergolines / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007980:Levodopa / Q000009:adverse effects / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D009460:Neurologic Examination; D010300:Parkinson Disease / Q000188:drug therapy*
D015259:Dopamine Agents; D004873:Ergolines; D007980:Levodopa; C031649:mesulergine